The Stop TB Partnership Announcement - 22 January 2020
Ending Tuberculosis is Good for Business:
New Initiative Launched to Catalyze Action to
End TB in the Workplace
The “Ending Workplace TB” initiative will bring together a group of partners from across industries and sectors to tackle the world’s number one infectious disease killer. 

Responsible businesses who join the initiative will have a huge impact on the health of their workforce and supply chains in high-burden countries and complement efforts of country governments

Davos, Switzerland, 21 January 2020 -  At the World Economic Forum (WEF) Annual Meeting, a multi-sectoral group of partners launched a new initiative – called Ending Workplace Tuberculosis (TB) – aimed at engaging major businesses in the fight against tuberculosis (TB). Initiated by the World Economic Forum; Johnson & Johnson; Royal Philips; Fullerton Health; the Confederation of Indian Industry; the Global Fund to Fight AIDS, Tuberculosis and Malaria; the United States Agency for International Development (USAID) and the Stop TB Partnership, this initiative will leverage the untapped potential of businesses in countries disproportionately impacted by TB to roll out awareness, detection and treatment programs, to reach millions of workers, their families and communities.

TB is the world’s deadliest infectious disease – killing 1.5 million people in 2018, more than HIV/AIDS and malaria deaths combined.  Of the 10 million new cases of TB, only 7 million were diagnosed, meaning that 3 million people with TB each year go unaccounted for. Many of these “missing millions” are in their most productive years and could potentially be reached through workplace and supply chain programs. 

“In high-burden areas, TB endangers the livelihoods of communities by reducing incomes and market sizes,” said Arnaud Bernaert, Head of Shaping the Future of Health and Health Care at the World Economic Forum. “Since employees spend the majority of their waking hours at work, the workplace is a logical place to tackle TB.”
 
In addition to its devastating human impact, TB costs the global economy US$12 billion annually.  Work absences necessitated by treatment and poor health make a large contribution to these costs. If efforts to fight TB continue at the same rate, TB is projected to cost the global economy US$983 billion over 15 years.

"The Ending Workplace TB initiative was launched at an event at the WEF Annual Meeting in Davos where leaders came together to speak about why it makes good business to end tuberculosis. Dr. Luiz Henrique Mandetta, Minister of Health of Brazil and Chair of the Stop TB Partnership Board, delivered a keynote address in which he spoke about the need for ambitious and inclusive leadership in the fight against TB – and the important role that public-private partnerships must play to end the TB epidemic.
 
“Businesses – particularly those with commercial, distribution and manufacturing operations in high TB-burden countries – can make a huge impact by fighting the effects of TB on their workforces and supply chains, complementing the efforts of local governments,” said Lynn Lau Executive Director at Fullerton Health Foundation. “In collaboration with our partners, this campaign is committing to help catalyze that.”

“New, bold and creative steps are required across sectors to disrupt the trajectory of this disease,” said Adrian Thomas, MD, Vice President, Global Public Health at Johnson & Johnson and Private Sector Board Member of the STOP TB Partnership. “Not only can businesses improve the health, safety and well-being of their workforces and supply chains by raising TB awareness and increasing access to TB prevention, screening, diagnosis, treatment and care – they can also improve productivity and reduce costs related to health care, staff turnover and absenteeism.”

“Ending TB requires a cross-sector and cross-industry effort,” added Peter Sands, Executive Director of the Global Fund.  “Business can take the lead to provide the right diagnostic and treatment services to their staff and encourage their suppliers to do the same. Doing this will not only support people and their families but reduce the negative economic impact of the disease.”
 
 “With this campaign, we can make a big difference,” concluded Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership. “The business sector already has programs for screening and testing of workers for different diseases, and it is very feasible to include TB in these programs. This campaign can show how the private sector can engage more fully in reaching the Sustainable Development Goals, specifically toward ending TB while protecting and taking care of their own workforces and supply chains.”

A Platform for Action Against Workplace TB


The Ending Workplace TB initiative will provide a platform for action by:

•    Securing commitments to tackle TB as a priority from multinational companies with presence in high TB-burden areas and in high TB-risk industries, through partner networks,
•    Ensuring access to technical support on the ground to facilitate the roll-out of TB awareness, prevention, detection, and/or treatment programs for workforces, and
•    Conducting advocacy to drive change in the codes of conduct for suppliers, as part of a broader dialogue on doing responsible business. The aim is to enable both access to health services and job protection for people with TB. 

These efforts will all be conducted in close coordination with local governments and will aim to build capacity in public-sector TB programs. The campaign also provides an opportunity to catalyze the implementation of new interventions, such as innovative diagnostics, and connect more people to TB care and treatment. 

Initial contributions to this initiative from founding partners Johnson & Johnson, Fullerton Health and The Confederation of Indian Industry include:

  • Johnson & Johnson Will Fight TB Through its Supply Chain

Johnson & Johnson is committing to leverage its internal resources to help suppliers across sectors – from manufacturing to research and development to logistics – conduct TB awareness-raising initiatives, as well as voluntary screening and referral, to care.

These efforts are part of Johnson & Johnson’s comprehensive 10-year initiative in support of global efforts to end TB, with a focus on improving the detection of undiagnosed cases of TB, broadening access to treatment for drug-resistant TB, and accelerating R&D to discover next-generation TB treatments.

  • Fullerton Health Launching: Women Empowerment in the Workplace (WOW-TB) 

With funding from the Stop TB Partnership’s TB REACH initiative, Fullerton Health and KNCV will roll out a workplace TB screening program with 150,000 workers across 250 factories in Indonesia this year.  Workers who are in highly dense work locations and who lack awareness of TB and accessing TB-related services are particularly vulnerable. 
This projects aims to create TB-free working conditions by empowering employers and workers to help themselves by

  1. Raising employee awareness of TB through education,
  2. Delivering mobile TB screening,
  3. Encouraging employers to prioritize workplace health and wellness and
  4. Building onsite capability and capacity through the provision of TB services linked to Indonesia’s National TB Program. 
  • Confederation of Indian Industry Launching Drive for a TB-Free Workplace

The Confederation of Indian Industry, in conjunction with the Central TB Division (CTD), the Government of India has developed a TB-Free Workplace Campaign that will catalyze private sector engagement in India in the fight against TB. 

This campaign will engage with multiple stakeholders and is supported by the Global Fund with the final objective of complementing the national goal for a TB-Free India by 2025.

  • USAID Galvanizing Corporations to End TB with Corporate TB Pledge
In April 2019, U.S. Ambassador to India Kenneth Juster launched USAID’s “TB Pledge: Workplace and Corporate Social Responsibility Initiative," in partnership with India’s Ministry of Health and Family Welfare and Indian and American Business Associations. The Pledge has galvanized over 60 companies, who have committed resources to spread TB awareness, train healthcare providers, strengthen diagnostic facilities, promote active case finding, support results-based TB programs, and increase access to TB treatment for employees and communities. Based on four Pledge commitment levels, it enables corporations to design TB programs based on their resources and local contexts. Activities by TB Pledge companies reach over 100,000 people per month.
Confederation of Indian Industry 
The Confederation of Indian Industry (CII) works to create and sustain an environment conducive to the development of India, partnering industry, Government, and civil society, through advisory and consultative processes.  CII is a non-government, not-for-profit, industry-led and industry-managed organization, playing a proactive role in India's development process. Founded in 1895 and celebrating 125 years in 2020, India's premier business association has more than 9100 members, from the private as well as public sectors, including SMEs and MNCs, and an indirect membership of over 300,000 enterprises from 291 national and regional sectoral industry bodies.

Fullerton Health
Fullerton Health is a leading integrated health system in the Asia Pacific region. Founded in Singapore in 2010, today the Company serves clients through over 500 healthcare facilities and a large global network of healthcare providers across nine markets in Asia Pacific. Fullerton Health’s value proposition is the integration of healthcare service offerings with customized management and advisory capabilities, in line with its purpose to deliver affordable and accessible care for all in Asia Pacific. 

Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity. 

Royal Philips
Royal Philips is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.

Stop TB Partnership
The Stop TB Partnership is a unique United Nations hosted entity based in Geneva, Switzerland, committed to revolutionizing tuberculosis (TB) space to end the disease by 2030. The organization aligns over 2,000 partners globally to promote cross-sectoral collaboration. The Stop TB Partnership’s various teams and initiatives take bold and smart risks to identify, fund and support innovative approaches, ideas, and solutions to ensure the TB community has a voice at the highest political levels and that all TB affected people have access to affordable, quality, and people-centered care. 

The Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund is a partnership designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics. As an international organization, the Global Fund mobilizes and invests more than US$4 billion a year to support programs run by local experts in more than 100 countries. In partnership with governments, civil society, technical agencies, the private sector and people affected by the diseases, we are challenging barriers and embracing innovation.


United States Agency for International Development (USAID)
USAID is the world's premier international development agency and a catalytic actor driving development results. USAID's work advances U.S. national security and economic prosperity, demonstrates American generosity, and promotes a path to recipient self-reliance and resilience.

World Economic Forum
The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. 
Copyright © 2019 Stop TB Partnership, All rights reserved.


Stop TB Partnership Secretariat
communications@stoptb.org
United Nations Office for Project Services
Chemin du Pommier 40
1218 Le Grand-Saconnex, Geneva
Switzerland